Wealthcare Advisory Partners LLC Amgen Inc Transaction History

Wealthcare Advisory Partners LLC

$3.49 Billion
Q4 2024

A detailed history of Wealthcare Advisory Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 13,313 shares of AMGN stock, worth $4.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

13,313

Previous 12,897 3.23%

Holding current value

$4.25 Million

Previous $4.16 Million 16.51%

% of portfolio

0.1%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	BUY	$258.78 - $328.31 $107,652 - $136,576	416 Added 3.23%	13,313 $3.47 Million
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $65,279 - $71,187	211 Added 1.66%	12,897 $4.16 Million
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $15,239 - $18,519	-58 Reduced 0.46%	12,686 $3.96 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $322,106 - $388,822	1,198 Added 10.38%	12,744 $3.62 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $64,436 - $72,691	252 Added 2.23%	11,546 $3.33 Million
Q3 2023 Oct 12, 2023	BUY	$218.65 - $271.46 $114,353 - $141,973	523 Added 4.86%	11,294 $3.04 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $35,997 - $42,566	168 Added 1.58%	10,771 $2.39 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $395,358 - $481,875	1,751 Added 19.78%	10,603 $2.56 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $174,520 - $221,749	762 Added 9.42%	8,852 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $18,854 - $21,264	84 Added 1.05%	8,090 $1.82 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1,384 - $1,540	-6 Reduced 0.07%	8,006 $1.95 Million
Q1 2022 Apr 15, 2022	BUY	$219.27 - $242.57 $13,814 - $15,281	63 Added 0.79%	8,012 $1.94 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $409,692 - $468,856	-2,060 Reduced 20.58%	7,949 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $63,044 - $73,863	297 Added 3.06%	10,009 $2.13 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $4,905 - $5,441	-21 Reduced 0.22%	9,712 $2.37 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $3,550 - $4,137	-16 Reduced 0.16%	9,733 $2.42 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $580,114 - $690,813	2,681 Added 37.93%	9,749 $2.24 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $8,682 - $9,655	37 Added 0.53%	7,068 $1.8 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $34,814 - $42,722	-176 Reduced 2.44%	7,031 $1.66 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $3,644 - $4,834	-20 Reduced 0.28%	7,207 $1.46 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $926,750 - $1.19 Million	4,898 Added 210.3%	7,227 $1.74 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $50,491 - $60,499	290 Added 14.22%	2,329 $451,000
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $3,334 - $3,908	20 Added 0.99%	2,039 $376,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $7,415 - $8,359	41 Added 2.07%	2,019 $384,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $2,497 - $2,915	-14 Reduced 0.7%	1,978 $385,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $2,964 - $3,342	-16 Reduced 0.8%	1,992 $413,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $139,814 - $157,041	842 Added 72.21%	2,008 $371,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $7,285 - $8,514	-43 Reduced 3.56%	1,166 $199,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $154,442 - $172,559	915 Added 311.22%	1,209 $210,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $49,183 - $56,154	294	294 $55,000

Others Institutions Holding AMGN

# of Institutions

3,179

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account

Wealthcare Advisory Partners LLC Amgen Inc Transaction History